Showing results (1-10 of 249) with videos related to
Sort By:
Pageof 25
Diabetes & Metabolism|October 3, 2008
The metabolic syndrome, diabetes and lung dysfunctionA Tiengo, G P Fadini, A AvogaroDiabetes, Obesity & Metabolism|July 2, 2010
Potential manipulation of endothelial progenitor cells in diabetes and its complicationsG P Fadini, A AvogaroJournal of Endocrinological Investigation|September 3, 2015
Effects of dose escalating liraglutide from 1.2 to 1.8 mg in clinical practice: a case-control studyM Rigato, A Avogaro, G P FadiniJournal of Endocrinological Investigation|January 29, 2021
Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysisB M Bonora, A Avogaro, G P FadiniJournal of Endocrinological Investigation|July 26, 2018
Exposure to insulin degludec during pregnancy: report of a small series and review of the literatureB M Bonora, A Avogaro, G P FadiniActa Diabetologica|April 18, 2019
Effects of exenatide long-acting release on cardiovascular events and mortality in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trialsB M Bonora, A Avogaro, G P FadiniNutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 19, 2010
Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetesS Vigili de Kreutzenberg, A Coracina, A Volpi, et al.Cardiovascular Diabetology|May 11, 2021
Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetesV Sciannameo, P Berchialla, A Avogaro, et al.Journal of Endocrinological Investigation|August 1, 2020
Incidence of heart failure in patients with type 1 diabetes: a systematic review of observational studiesA Avogaro, D Azzolina, G P Fadini, et al.The European Respiratory Journal|February 4, 2010
Endothelial progenitors in pulmonary hypertension: new pathophysiology and therapeutic implicationsG P Fadini, A Avogaro, G Ferraccioli, et al.Pageof 25